BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38149107)

  • 1. An Automated Virtual Reality Program Accurately Diagnoses HIV-Associated Neurocognitive Disorders in Older People With HIV.
    Moore RC; Kuehn KS; Heaton A; Sundermann EE; Campbell LM; Torre P; Umlauf A; Moore DJ; Kosoris N; Wright DW; LaPlaca MC; Waldrop D; Anderson AM
    Open Forum Infect Dis; 2023 Dec; 10(12):ofad592. PubMed ID: 38149107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a new computer simulated environment to screen cognition: assessing the feasibility and acceptability of Leaf Café in younger and older adults.
    Siette J; Guion J; Ijaz K; Strutt P; Porte M; Savage G; Richards D
    BMC Med Inform Decis Mak; 2024 Mar; 24(1):79. PubMed ID: 38504250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
    Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW
    J Neurovirol; 2016 Dec; 22(6):816-822. PubMed ID: 27245594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for neuropsychological health disparities in Black Americans with HIV disease.
    Thompson JL; Beltran-Najera I; Johnson B; Morales Y; Woods SP
    Clin Neuropsychol; 2022 Feb; 36(2):388-413. PubMed ID: 35166174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild Cognitive Impairment, But Not HIV Status, is Related to Reduced Awareness of Level of Cognitive Performance Among Older Adults.
    Harvey PD; Strassnig A; Strassnig M; Heaton A; Kuehn K; Torre P; Sundermann EE; Pinkham A; Depp CA; Black G; Wharton W; Waldrop D; Anderson AM; Moore RC
    Am J Geriatr Psychiatry; 2023 Dec; 31(12):1117-1128. PubMed ID: 37544836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensemble machine learning classification of daily living abilities among older people with HIV.
    Paul R; Tsuei T; Cho K; Belden A; Milanini B; Bolzenius J; Javandel S; McBride J; Cysique L; Lesinski S; Valcour V
    EClinicalMedicine; 2021 May; 35():100845. PubMed ID: 34027327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study.
    Milanini B; Catella S; Perkovich B; Esmaeili-Firidouni P; Wendelken L; Paul R; Greene M; Ketelle R; Valcour V
    AIDS Care; 2017 Sep; 29(9):1178-1185. PubMed ID: 28127989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.
    Jia P; Zhao Z; Hulgan T; Bush WS; Samuels DC; Bloss CS; Heaton RK; Ellis RJ; Schork N; Marra CM; Collier AC; Clifford DB; Gelman BB; Sacktor N; Morgello S; Simpson DM; McCutchan JA; Barnholtz-Sloan JS; Franklin DR; Rosario D; Letendre SL; Grant I; Kallianpur AR;
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):413-426. PubMed ID: 28447399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-year longitudinal randomized controlled trial examining the transfer of speed of processing training to secondary cognitive domains in middle-aged and older adults with HIV-associated neurocognitive disorder: Results of the think fast study.
    Vance DE; Fazeli PL; Azuero A; Frank JS; Wadley VG; Raper JL; Pope CN; Ball KK
    Clin Neuropsychol; 2024 Feb; 38(2):471-492. PubMed ID: 37191339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.
    Campbell LM; Fennema-Notestine C; Saloner R; Hussain M; Chen A; Franklin D; Umlauf A; Ellis RJ; Collier AC; Marra CM; Clifford DB; Gelman BB; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Heaton RK;
    J Int Neuropsychol Soc; 2020 Feb; 26(2):147-162. PubMed ID: 31576785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of HIV-Associated Neurocognitive Impairment in Middle-Aged and Older Persons With HIV in Lima, Peru.
    Diaz MM; Zacarías MG; Sotolongo P; Sanes MF; Franklin DJ; Marquine MJ; Cherner M; Cárcamo C; Ellis RJ; Lanata S; García PJ
    Front Neurol; 2021; 12():629257. PubMed ID: 34220665
    [No Abstract]   [Full Text] [Related]  

  • 14. Examining virtual driving test performance and its relationship to individuals with HIV-associated neurocognitive disorders.
    Grethlein D; Pirrone V; Devlin KN; Dampier W; Szep Z; Winston FK; Ontañón S; Walshe EA; Malone K; Tillman S; Ances BM; Kandadai V; Kolson DL; Wigdahl B
    Front Neurosci; 2022; 16():912766. PubMed ID: 36090285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
    Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
    PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.
    Chan LG; Ho MJ; Lin YC; Ong Y; Wong CS
    AIDS Res Ther; 2019 Apr; 16(1):9. PubMed ID: 30987670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
    Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M;
    Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal cognitive aging in people with HIV: evidence from data integration between two countries' cohort studies.
    Aung HL; Gates TM; Mao L; Brew BJ; Rourke SB; Cysique LA
    AIDS; 2022 Jul; 36(8):1171-1179. PubMed ID: 35471252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphisms in aquaporin-4 associate with cognitive impairment status in people with HIV.
    Tice C; Zhao H; Langford D
    J Neurovirol; 2023 Jun; 29(3):258-271. PubMed ID: 37191905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.